His primary areas of study are Cell biology, Receptor, Apoptosis, Signal transduction and Ceramide. His Cell biology research is multidisciplinary, incorporating elements of Cell culture, Biochemistry, N-Acetylneuraminic acid and Cell adhesion, Neural cell adhesion molecule. His work deals with themes such as Cell and Molecular biology, which intersect with Receptor.
His research integrates issues of Cell surface receptor and Intracellular in his study of Signal transduction. His studies in Intracellular integrate themes in fields like Lymphocyte and Ligand. His study in Ceramide is interdisciplinary in nature, drawing from both Sphingomyelin, Programmed cell death, Mitochondrial permeability transition pore, Apoptosis-inducing factor and Mitochondrion.
His main research concerns Cell biology, Apoptosis, Frataxin, Ataxia and Cancer research. His studies deal with areas such as Ceramide and Biochemistry as well as Cell biology. As part of the same scientific family, Roberto Testi usually focuses on Apoptosis, concentrating on Immunology and intersecting with In vivo, Secretion and Aminosalicylic acid.
His Frataxin study combines topics in areas such as Ubiquitin, Aconitase and Iron-binding proteins. In his study, which falls under the umbrella issue of Cancer research, Tyrosine kinase is strongly linked to Proto-oncogene tyrosine-protein kinase Src. His research integrates issues of Receptor and Cell type in his study of Signal transduction.
Ataxia, Frataxin, Cell biology, Cancer research and Gene silencing are his primary areas of study. The various areas that Roberto Testi examines in his Ataxia study include Clinical trial, Mutation, Gene, Immunology and Interferon gamma. His Frataxin study is concerned with the larger field of Mitochondrion.
The study incorporates disciplines such as Downregulation and upregulation and Proto-oncogene tyrosine-protein kinase Src in addition to Cancer research. His Downregulation and upregulation research includes elements of Molecular biology and Cell type. Ubiquitin is a subfield of Biochemistry that he tackles.
Roberto Testi mainly focuses on Frataxin, Ataxia, Cell biology, Ubiquitin and Biochemistry. Roberto Testi interconnects Protein degradation, Caenorhabditis elegans, Interferon gamma and Iron-binding proteins in the investigation of issues within Frataxin. His Caenorhabditis elegans research is multidisciplinary, incorporating perspectives in Autophagy, Cellular adaptation, Lipid metabolism, RNA interference and Gene silencing.
His Ataxia research is multidisciplinary, incorporating elements of Peripheral blood mononuclear cell and Pathology. His Ubiquitin study incorporates themes from HEK 293 cells, Aconitase, Programmed cell death and Proteasome. His work deals with themes such as Molecular biology, Cancer research, Downregulation and upregulation and Cell type, which intersect with Mitochondrion.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Potential Involvement of Fas and Its Ligand in the Pathogenesis of Hashimoto's Thyroiditis
Carla Giordano;Giorgio Stassi;Ruggero De Maria;Matilde Todaro.
Science (1997)
Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase.
M G Cifone;R De Maria;P Roncaioli;M R Rippo.
Journal of Experimental Medicine (1994)
The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells
Roberto Testi;Roberto Testi;Daniele D'Ambrosio;Daniele D'Ambrosio;Ruggero De Maria;Ruggero De Maria;Angela Santoni;Angela Santoni.
Immunology Today (1994)
Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule.
L L Lanier;R Testi;J Bindl;J H Phillips.
Journal of Experimental Medicine (1989)
Requirement for GD3 Ganglioside in CD95- and Ceramide-Induced Apoptosis
Ruggero De Maria;Luisa Lenti;Florence Malisan;Federica d'Agostino.
Science (1997)
Multiple pathways originate at the Fas/APO-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal.
M. G. Cifone;P. Roncaioli;R. De Maria;G. Camarda.
The EMBO Journal (1995)
T cell activation via Leu-23 (CD69).
R Testi;J H Phillips;L L Lanier.
Journal of Immunology (1989)
Nitric Oxide Primes Pancreatic β Cells for Fas-mediated Destruction in Insulin-dependent Diabetes Mellitus
Giorgio Stassi;Ruggero De Maria;Giuliana Trucco;William Rudert.
Journal of Experimental Medicine (1997)
Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C.
R Testi;J H Phillips;L L Lanier.
Journal of Immunology (1989)
Sphingomyelin breakdown and cell fate
Roberto Testi.
Trends in Biochemical Sciences (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Sapienza University of Rome
Catholic University of the Sacred Heart
University of Rome Tor Vergata
Sapienza University of Rome
University of California, San Francisco
University of Rome Tor Vergata
MSD (United States)
University of Palermo
University of Colorado Boulder
German Center for Neurodegenerative Diseases
Kyungpook National University
Hokkaido University
University of Wisconsin–Madison
University of Leoben
Center for International Forestry Research, Peru
Wageningen University & Research
Paris-Est Créteil University
Asian University
National Institutes of Health
Korea Institute of Science and Technology
Karolinska Institute
University of Florida
Concordia University
Rutgers, The State University of New Jersey
The University of Texas Southwestern Medical Center
University of Haifa